Tumors or cancer of the UTERINE CERVIX.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. (1/6661)

AIM: To test a new assay for the detection of human papillomavirus (HPV) DNA, hybrid capture II (HC II), compared with the previous commercialized hybrid capture I (HC I) and polymerase chain reaction (PCR) results on cervical scrapes from fresh cone excision biopsy samples. METHODS: The three methods were used on cervical scrapes from 42 fresh cone excision biopsy samples. There were nine metaplastic and inflammatory lesions, five low grade lesions, and 28 high grade lesions. PCR was performed using the general primers GP5+/GP6+. The viral load of high risk HPV DNA was estimated by the ratio of relative light units to positive control values in the samples. RESULTS: The sensitivity of HC I for the detection of high grade lesions was 71.4%, while it was 92.8% for HC II and 96.4% for the PCR. Considering only the absence of detectable cervical in situ neoplasia, the specificity was 88.9% for HC I, 66.7% for HC II, and 66.7% for PCR. With HC II, for a ratio of cervical sample to normal control of > 200, the sensitivity for the detection of high grade lesion was only 34.6% with a specificity of 66.7%. CONCLUSIONS: HPV detection with the HC II assay is more sensitive than the previous HC I and represents a more convenient and easier test than PCR for routine use. Nevertheless the viral load estimated with this test cannot be a reliable predictive indicator of high grade lesions.  (+info)

Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. (2/6661)

AIM: To investigate the immunocytochemical staining pattern of mdm2 and p21WAF1 proteins in invasive cervical cancer and to determine its relation with the expression of p53 and with the high risk HPV infection. METHODS: Immunocytochemistry for p53, mdm2, and p21WAF1 was performed in 31 paraffin embedded sections of invasive cervical cancer. The results were assessed by image analysis, evaluating for each protein the optical density of the immunostained area, scored as percentage of the total nuclear area. The presence of high risk human papillomavirus (HPV) infection was detected by using the polymerase chain reaction. RESULTS: Immunostaining for both mdm2 and p21WAF1 was correlated with p53 expression; however, the correlation between p53 and mdm2 (R = 0.49; p < 0.01) was more significant than between p53 and p21WAF1 (R = 0.31; p < 0.05); the less stringent correlation between p53 and p21WAF1 might reflect the p53 independent mechanisms of p21WAF1 induction. Similar average levels of p53, mdm2, and p21WAF1 immunostaining were found in the presence or absence of high risk HPV-DNA, without significant differences between the two groups. CONCLUSIONS: These data suggest that mdm2 and p21WAF1 proteins are expressed in invasive cervical cancer and that their immunocytochemical staining pattern is not abrogated by the presence of high risk HPV genomic sequences.  (+info)

Expression of extracellular matrix proteins in cervical squamous cell carcinoma--a clinicopathological study. (3/6661)

AIM: To evaluate the intracellular and peritumoral expression of matrix proteins in squamous cell carcinoma of the uterine cervix using immunohistochemistry. METHODS: 71 squamous cell carcinomas and 10 controls were stained for laminin, fibronectin, and collagen IV. Cytoplasmic staining in tumour cells and peritumoral deposition of matrix proteins were evaluated. The association between staining results and patient age, tumour stage, histological grade, and survival was studied. RESULTS: Positive cytoplasmic staining for laminin, fibronectin, and collagen IV was observed in 17 (23.9%), 27 (38%), and 10 (14.1%) cases, respectively. Staining for laminin was most pronounced in the invasive front of tumour islands, while for fibronectin and collagen IV it appeared to be diffuse. Peritumoral staining for laminin and collagen IV was detected in 12 cases (16.9%). Early stage (Ia1-Ia2) tumours were uniformly negative for all three proteins. Cytoplasmic staining for laminin correlated with positive staining for fibronectin and collagen IV, and with the presence of a peritumoral deposition of collagen IV and laminin. There was no correlation with any of the three markers between staining results and patient age, stage, grade, or survival. CONCLUSIONS: Expression of extracellular matrix proteins in some cervical squamous cell carcinomas might reflect the enhanced ability of these tumours to modify the peritumoral stroma. This ability seems to be absent in early stage tumours. The correlation between intracytoplasmic and peritumoral expression of matrix proteins supports the evidence of their synthesis by tumour cells. However, this property did not correlate with disease outcome in this study.  (+info)

Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour. (4/6661)

The United Kingdom (UK) cervical screening programme has been successful in securing participation of a high proportion of targeted women, and has seen a fall in mortality rates of those suffering from cervical cancer. There remains, however, a significant proportion of unscreened women and, of women in whom an abnormality is detected, many will not attend for colposcopy. The present work reviews the psychological consequences of receiving an abnormal cervical smear result and of secondary screening and treatment, and examines reasons for women's non-participation in the screening programme. Psychological theories of screening behavior are used to elucidate women's reactions and to suggest methods of increasing participation, of improving the quality of the service, and of reducing women's anxiety. A literature search identified studies that examine factors influencing women's participation in the screening programme, their psychological reaction to the receipt of an abnormal cervical smear result, and experiences of colposcopy. Reasons for non-participation include administrative failures, unavailability of a female screener, inconvenient clinic times, lack of awareness of the test's indications and benefits, considering oneself not to be at risk of developing cervical cancer, and fear of embarrassment, pain, or the detection of cancer. The receipt of an abnormal result and referral for colposcopy cause high levels of distress owing to limited understanding of the meaning of the smear test; many women believe the test aims to detect existing cervical cancer. The quality of the cervical screening service can be enhanced by the provision of additional information, by improved quality of communication, and by consideration of women's health beliefs. This may result in increased participation in, and satisfaction with, the service.  (+info)

Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers. (5/6661)

Carcinoma of the uterine cervix is a common malignancy among women that has been found to show loss of heterozygosity in the chromosome 11p. Recent studies have localized the TSG101 gene in this region, and also demonstrated a high frequency of abnormalities of this gene in human breast cancer. To determine the role of the TSG101 gene in the carcinogenesis of cervical and uterine carcinoma, 19 cases of cervical carcinoma and five cases of endometrial carcinoma, as well as nearby non-cancerous tissue from the same patients, and 16 blood samples from healthy persons as normal control were analysed by Southern blot analysis of genomic DNA, reverse transcription of the TSG101 mRNA followed by PCR amplification and sequencing of the products. We found that abnormal transcripts of the TSG101 gene were common both in cancerous or non-cancerous tissues of the uterus and cervix and in normal peripheral mononuclear cells. There was no genomic deletion or rearrangement in spite of the presence of abnormal transcripts, and no definite relationship between the abnormal transcripts and HPV infection was found. Although the frequency of abnormal transcripts was higher in cancerous than in non-cancerous tissue, normal peripheral mononuclear cells also had abnormal transcripts. Given these findings, the role of the TSG101 gene as a tumour-suppressor gene should be re-evaluated. Because some aberrant transcripts could be found at the first PCR reaction, we suggest that the aberrant transcripts might be the result of imperfect minor splicesome products.  (+info)

A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. (6/6661)

To investigate involvement of an aberrant expression of the FHIT (fragile histidine triad) gene in the process of carcinogenesis and progression in cervical carcinoma, we examined its expression by the reverse transcriptase polymerase chain reaction (RT-PCR) and cDNA sequence method in 32 cervical invasive carcinomas (25 squamous cell carcinomas and seven adeno- or adenosquamous carcinomas) and 18 of its precursor lesions [four low-grade and 14 high-grade cervical intraepithelial neoplasias (CINs)]. We also examined a link between the occurrence of the aberrant expression and human papillomavirus (HPV). We detected the aberrant FHIT transcripts in 11 of 25 (44%) cervical invasive squamous cell carcinomas and in 5 of 14 (36%) high-grade CINs (CIN 2 or 3), whereas they were not found in seven non-squamous type and four low-grade CINs (CIN 1). The alteration patterns of the FHIT gene expression in high-grade CINs were virtually similar to those found in invasive carcinomas, such that the exons 5-7 were consistently deleted associated or unassociated with loss of the exon 4 and/or 8. The incidence of the aberrant expression was not related to the presence of HPV and its type. These data indicate that the aberrant expression of the FHIT gene is observed in precursor lesions of cervical carcinoma as well as invasive carcinomas, with its incidence not increasing with advance of clinical stage. Given the squamous cell type dominant expression, the aberrant expression may play a critical role in the generation of squamous cell carcinoma of the uterine cervix, but not the consequence of the progression of the cancer.  (+info)

Modulation of the cytotoxicity of 3'-azido-3'-deoxythymidine and methotrexate after transduction of folate receptor cDNA into human cervical carcinoma: identification of a correlation between folate receptor expression and thymidine kinase activity. (7/6661)

Cervical carcinoma is an AIDS-defining illness. The expression of folate receptors (FRs) in cervical carcinoma (HeLa-IU1) cells was modulated by stable transduction of FR cDNA encapsidated in recombinant adeno-associated virus-2 in the sense and antisense orientation (sense and antisense cells, respectively). Although sense cells proliferated slower than antisense or untransduced cells in vivo and in vitro in 2% (but not 10%) FCS, [methyl-3H]thymidine incorporation into DNA was significantly increased in sense cells in 10% serum; therefore, the basis for this discrepancy was investigated. The activity of thymidine kinase (TK) was subsequently directly correlated with the extent of FR expression in single cell-derived clones of transduced cells. This elevated TK activity was not a result of recruitment of the salvage pathway based on the presence of adequate dTTP pools, normal thymidylate synthase (TS) activity, persistence of increased thymidine incorporation despite the exogenous provision of excess 5,10-methylene-tetrahydrofolate, and documentation of adequate folates in sense cells. The increase in TK activity conferred significant biological properties to sense cells (but not antisense or untransduced cells) as demonstrated by augmented phosphorylation of 3'-azido-3'-deoxythymidine (AZT) and concomitantly greater sensitivity to the cytotoxic effects of AZT. Conversely, sense cells were highly resistant to methotrexate, but this was reversed by the addition of AZT. The direct correlation of FR expression and TK activity indicates a previously unrecognized consequence of FR overexpression.  (+info)

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. (8/6661)

BACKGROUND: Human papillomavirus (HPV) infection is associated with precancerous cervical squamous intraepithelial lesions commonly seen among women infected with human immunodeficiency virus-1 (HIV). We characterized HPV infection in a large cohort of HIV-positive and HIV-negative women participating in the Women's Interagency HIV Study to determine the prevalence of and risk factors for cervicovaginal HPV infection in HIV-positive women. METHODS: HIV-positive (n = 1778) and HIV-negative (n = 500) women were tested at enrollment for the presence of HPV DNA in a cervicovaginal lavage specimen. Blood samples were tested for HIV antibody status, level of CD4-positive T cells, and HIV RNA load (copies/mL). An interview detailing risk factors was conducted. Univariate and multivariate analyses were performed. RESULTS: Compared with HIV-negative women, HIV-positive women with a CD4+ cell count of less than 200/mm3 were at the highest risk of HPV infection, regardless of HIV RNA load (odds ratio [OR] = 10.13; 95% confidence interval [CI] = 7.32-14.04), followed by women with a CD4+ count greater than 200/mm3 and an HIV RNA load greater than 20,000 copies/mL (OR = 5.78; 95% CI = 4.17-8.08) and women with a CD4+ count greater than 200/mm3 and an HIV RNA load less than 20,000 copies/mL (OR = 3.12; 95% CI = 2.36-4.12), after adjustment for other factors. Other risk factors among HIV-positive women included racial/ethnic background (African-American versus Caucasian, OR = 1.64; 95% CI = 1.19-2.28), current smoking (yes versus no; OR = 1.55; 95% CI = 1.20-1.99), and younger age (age < 30 years versus > or = 40 years; OR = 1.75; 95% CI = 1.23-2.49). CONCLUSIONS: Although the strongest risk factors of HPV infection among HIV-positive women were indicators of more advanced HIV-related disease, other factors commonly found in studies of HIV-negative women, including racial/ethnic background, current smoking, and age, were important in HIV-positive women as well.  (+info)

Uterine cervical neoplasms, also known as cervical cancer or cervical dysplasia, refer to abnormal growths or lesions on the lining of the cervix that have the potential to become cancerous. These growths are usually caused by human papillomavirus (HPV) infection and can be detected through routine Pap smears.

Cervical neoplasms are classified into different grades based on their level of severity, ranging from mild dysplasia (CIN I) to severe dysplasia or carcinoma in situ (CIN III). In some cases, cervical neoplasms may progress to invasive cancer if left untreated.

Risk factors for developing cervical neoplasms include early sexual activity, multiple sexual partners, smoking, and a weakened immune system. Regular Pap smears and HPV testing are recommended for early detection and prevention of cervical cancer.

Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.

Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.

Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.

There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.

It is also overexpressed in uterine corpus endometrial and uterine carcinosarcomas. Another F-protein-protease is tryptase beta ... Its expression is also increased in a wide range of other malignant neoplasms. Factor X (F10) is frequently expressed in normal ... TMPRSS2 is overexpressed in cervical and endocervical squamous cell carcinomas, along with colon, prostate, and rectum ... It is also overexpressed in some cell lines originating from various malignant neoplasms. Thus, it is highly expressed in ...
... infection and neoplasms of cervical origin. The majority of SCCs of uterine cervix express p16. However, p16 can be expressed ... p16 can be used as a biomarker to improve the histological diagnostic accuracy of grade 3 cervical intraepithelial neoplasia ( ... p16 immunohistochemical expression alone cannot be used to discriminate between SCCs arising from uterine cervix versus urinary ... CIN). p16 is also implicated in the prevention of melanoma, oropharyngeal squamous cell carcinoma, cervical cancer, vulvar ...
Types include: Cancer of the female genital organs: (Cervical cancer, Endometrial cancer, Ovarian cancer, Uterine cancer, ... A urogenital neoplasm is a tumor of the urogenital system. ... Neoplasm stubs, Disease stubs, Genitourinary system stubs). ...
... and Uterine Corpus Endometrial Carcinoma. MORT is silenced in cervical cancer and therefore may serve as an independent ... lymphoid neoplasm diffuse large B-cell lymphoma, pancreatic adenocarcinoma, rectum adenocarcinoma, skin cutaneous melanoma, ... Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer ...
... uterine cancer, prostate cancer[citation needed], lung cancer and cervical cancer. Other associated underlying malignancies ... It is likely directly induced by an underlying neoplasm secreting a growth factor. One candidate may be alpha-transforming ... Acanthosis Nigricans and Florid Cutaneous Papillomatosis in a Patient with Metastatic Cervical Cancer", Dermatol Sin, 22: 142- ...
In 1870 Gusserow was the first physician to describe a rare type of uterine cervical adenocarcinoma that is sometimes referred ... Among his better written efforts was Die Neubildungen des Uterus (Neoplasms of the uterus). Zur Lehre vom Stoffwechsel des ... Cytologic and Cytochemical features of Adenoma Malignum of the Uterine Cervix Libri.de (short biography of Adolf Gusserow) ( ...
... and cervical cancer. Additionally, hematometra may develop as a complication of uterine or cervical surgery such as endometrial ... a biopsy of endometrial tissue can be taken to test for the presence of a neoplasm (cancer). Antibiotics may be given as ... Hematometra is usually treated by surgical cervical dilation to drain the blood from the uterus. Other treatments target the ... Other causes are acquired, such as cervical stenosis, intrauterine adhesions, endometrial cancer, ...
Symptoms of cervical adenosarcoma, like uterine adenosarcoma, are characterized by abnormal bleeding. Treatment mainly consists ... Malignant neoplasms arising in endometriosis: clinicopathological study of 14 cases. Clin Exp Obstet Gynecol. 2004;31(4):302-4 ... Uterine adenosarcoma are a subtype of uterine sarcomas. Uterine sarcomas account for 3 to 9% of uterine cancers, and 5.5 to 9% ... Uterine adenosarcoma commonly arise from the endometrium. Uterine adenosarcomas have the highest incidence in perimenopausal ...
Myung SK, Ju W, Kim SC, Kim H (October 2011). "Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a ... "Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer". American ... Stage 1A cervical cancer Stage 1B cervical cancer Stage 2A cervical cancer Stage 2B cervical cancer Stage 3B cervical cancer ... Cervical intraepithelial neoplasia, the potential precursor to cervical cancer, is often diagnosed on examination of cervical ...
Cervical dyskaryosis is classified into three degrees of severity: mild dyskaryosis, moderate and severe. A further category is ... This may be followed by the development of a malignant neoplasm. Dyskaryosis is used synonymously with dysplasia, which is the ... ". "Dyskaryosis" is a term used for all squamous mucosal surfaces and commonly used for the uterine cervix condition in which ... Dyskaryosis means abnormal nucleus and refers to the abnormal epithelial cell which may be found in cervical sample. It is ...
... uterine cervical incompetence MeSH C13.371.852.150.131 - uterine cervical neoplasms MeSH C13.371.852.150.150 - uterine ... uterine cervical diseases MeSH C13.371.852.150.074 - uterine cervical dysplasia MeSH C13.371.852.150.112 - uterine cervical ... uterine cervical neoplasms MeSH C13.371.852.833 - uterine prolapse MeSH C13.371.852.904 - uterine rupture MeSH C13.371.852.904. ... uterine cervical neoplasms MeSH C13.371.820.800.418.937 - vaginal neoplasms MeSH C13.371.820.800.418.968 - vulvar neoplasms ...
"Uterine Neoplasms". Journal of the National Comprehensive Cancer Network. 7 (5): 498-531. doi:10.6004/jnccn.2009.0035. ISSN ... Cervix Cervical cancer Villoglandular adenocarcinoma Low mag. High mag. Nasu, K.; Takai, N.; Narahara, H. (Jun 2009). " ... 2004). "Glassy cell carcinoma of the uterine cervix a rare histology. Report of three cases with a review of the literature". ... Glassy cell carcinoma of the cervix, also glassy cell carcinoma, is a rare aggressive malignant tumour of the uterine cervix. ...
Urethral cancer Uterine sarcoma Vaginal cancer Vulvar cancer Wilms tumor (nephroblastoma) Esophageal cancer Head and neck ... islet cell Rectal cancer Small intestine cancer Bladder cancer Cervical cancer Endometrial cancer Extragonadal germ cell tumor ... Marginal zone B-cell lymphoma Mast cell leukemia Mediastinal large B cell lymphoma Multiple myeloma/plasma cell neoplasm ...
A Cochrane review indicates women with high stage uterine carcinosarcoma (stage 3 or 4) who were treated with combination ... and sometimes protrude through the cervical os. On histology, the tumors consist of adenocarcinoma (endometrioid, serous or ... Connective and soft tissue neoplasms). ... Staging of uterine MMMTs is as follows: Stage I. Carcinoma is ... February 2013). "Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma". The Cochrane Database of ...
... neoplasm, most commonly cervical cancer, and hematologic disorders. Molar pregnancy (also called hydatiform mole) is a type of ... Besides placenta previa and placental abruption, uterine rupture can occur, which is a very serious condition leading to ... As well as cervical insufficiency defined as a midtrimester (14th-26th week) dilation of the cervix which may need medical ... Causes of bleeding before and during childbirth include cervicitis, placenta previa, placental abruption and uterine rupture. ...
Cervical squamous intraepithelial lesion (SIL), previously called cervical intraepithelial neoplasia (CIN), is a form of ... Dysplasia of the uterine cervix is removed by excision (cutting it out) or by burning with a laser. Bowen's disease of the skin ... While they are a form of neoplasm, there is disagreement over whether CIS should be classified as cancer. This controversy also ... "Understanding Cervical Changes" (PDF). National Cancer Institute. National Institute of Health. Retrieved 17 June 2014.[ ...
2003). "Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma". Oncology. 64 (4): 443-9. ... "Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms". Clinical Cancer Research. 9 (17): ... "Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas". ...
... uterine cervical neoplasms MeSH C04.588.945.418.955 - vaginal neoplasms MeSH C04.588.945.418.968 - vulvar neoplasms MeSH ... genital neoplasms, female MeSH C04.588.945.418.365 - fallopian tube neoplasms MeSH C04.588.945.418.948 - uterine neoplasms MeSH ... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ...
A cervical polyp is a common benign polyp or tumor on the surface of the cervical canal. They can cause irregular menstrual ... Some polyps are tumors (neoplasms) and others are non-neoplastic, for example hyperplastic or dysplastic, which are benign. The ... ISBN 978-1-900151-51-1. "Uterine polyps". MayoClinic.com. 2006-04-27. Retrieved 2007-10-20. Sternberg, Stephen S.; Stacey E. ... An endometrial polyp or uterine polyp is a polyp or lesion in the lining of the uterus (endometrium) that takes up space within ...
Brown-Séquard syndrome Cervical cancer "small-cell carcinoma" at Dorland's Medical Dictionary Nasu K, Hirakawa T, Okamoto M, ... Small-cell carcinoma is an undifferentiated neoplasm composed of primitive-appearing cells. As the name implies, the cells in ... March 2011). "Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and ...
... neoplasms, and cysts are skin lesions that develop from the epidermal layer of the skin. Aberrant basal cell carcinoma ... cervical accessory tragus, wattle) Congenital erosive and vesicular dermatosis Congenital hypertrophy of the lateral fold of ... Multinucleate cell angiohistocytoma Multiple cutaneous and uterine leiomyomatosis syndrome (leiomyomatosis cutis et uteri, ... an overview with emphasis on the myeloid neoplasms". Chem. Biol. Interact. 184 (1-2): 16-20. doi:10.1016/j.cbi.2009.10.009. ...
Prolapse of the uterus Carcinoma of the cervix - malignant neoplasm Carcinoma of the uterus - malignant neoplasm Fibroids - ... inflammation of the muscular uterine wall. Uterine malformations are mainly congenital malformations, and include uterus ... "Cervical Stenosis - Women's Health Issues - Merck Manuals Consumer Version". Merck Manuals Consumer Version. Archived from the ... During pregnancy, the uterine glands and blood vessels in the endometrium further increase in size and number and form the ...
14 Cervical cancer can be treated with either LDR, PDR or HDR brachytherapy. Used in combination with EBRT, brachytherapy can ... GammaTile is FDA-cleared to treat newly diagnosed, operable malignant intracranial neoplasms (i.e., brain tumors) and operable ... "High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix". Cancer. 94 (1): 117-124. doi: ... Brachytherapy is commonly used in the treatment of early or locally confined cervical cancer and is a standard of care in many ...
... in cervical carcinoma and cervical intraepithelial neoplasm". Anticancer Research. 23 (4): 3195-8. PMID 12926053. Iwasa S, Jin ... and uterine stroma. FAP expression is high in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing ...
The narrow, central cervical canal runs along its entire length, connecting the uterine cavity and the lumen of the vagina. The ... Papillary - In oncology, papillary refers to neoplasms with projections ("papillae", from Latin, 'nipple') that have ... Cervical cancer - is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to ... Brachial plexus - is a network of nerves formed by the ventral rami of the lower four cervical nerves and first thoracic nerve ...
They can develop further into a variety of other neoplasms, including choriocarcinoma, yolk sac tumor, and teratoma. They occur ... Histologically, they are similar to intestinal or cervical adenocarcinomas and are often actually metastases of appendiceal or ... CA-125 may also be elevated in benign (non-cancerous) conditions, including endometriosis, pregnancy, uterine fibroids, ... More typically, ovarian squamous cell carcinomas are cervical metastases, areas of differentiation in an endometrioid tumor, or ...
... in treatment of infertility in women when there is a need to develop sperm-friendly cervical mucous or an appropriate uterine ... "Pharmacology and Clinical Utility of Hormones in Hormone Related Neoplasms". In Alan C. Sartorelli, David G. Johns (eds.). ...
Uterine artery embolization (UAE) or uterine fibroid embolization (UFE) Prostate artery embolization (PAE) Pulmonary ... Used to treat patients with radicular symptoms in the cervical, thoracic, lumbar or sacral region. Helps to alleviate pain by ... such as osteoporosis or underlying neoplasm. Analogous to vertebroplasty, the purpose of sacroplasty is to provide ...
Uterus prior to hysterectomy Laparoscopical hysterectomy Cervical stump (white) after removal of the uterine corpus at ... "Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms". PLOS ONE. 7 (11): e50058. Bibcode: ... where the uterine lining has grown into and sometimes through the uterine wall musculature. This can thicken the uterine walls ... "Uterine Adenomyosis". Yale Medicine. Retrieved 2022-10-31. Uterine fibroids: Overview. Institute for Quality and Efficiency in ...
Benign neoplasms, Wikipedia medicine articles ready to translate, Uterine tumour). ... Cervical fibroids are located in the wall of the cervix (neck of the uterus). Rarely, fibroids are found in the supporting ... The prevalence of uterine fibroids among teenagers is 0.4%. The incidence of uterine fibroids in Europe is thought to be lower ... Uterine fibroids, also known as uterine leiomyomas or fibroids, are benign smooth muscle tumors of the uterus. Most women with ...
Learn about Uterine Cervical Neoplasms at online-medical-dictionary.org ... Cervical Cancers, Uterine. Cervical Neoplasm. Cervical Neoplasm, Uterine. Cervical Neoplasms. Cervical Neoplasms, Uterine. ... Neoplasms, Cervical. Neoplasms, Cervix. Neoplasms, Uterine Cervical. Uterine Cervical Cancer. Uterine Cervical Cancers. Uterine ... Cervix Neoplasm. Cervix Neoplasms. Neoplasm, Cervical. Neoplasm, Cervix. Neoplasm, Uterine Cervical. ...
Results of search for su:{Uterine cervical neoplasms} Refine your search. *. Availability. * Limit to currently available ... Screening for cancer of the uterine cervix / from the IARC Working Group on Cervical Cancer Screening and the UICC Project ... Second cancer in relation to radiation treatment for cervical cancer / from the International Radiation Study Group on Cervical ... Cervical screening : a practical guide / Ann McPherson. by McPherson, Ann.. Material type: Text; Format: print Publication ...
Most cervical cancer is caused by the HPV virus. It can often be cured if found early - learn how. ... ClinicalTrials.gov: Uterine Cervical Neoplasms (National Institutes of Health) Journal Articles References and abstracts from ... Cervical Cancer Symptoms (National Cancer Institute) Also in Spanish * Signs and Symptoms of Cervical Cancer (American Cancer ... Cervical Cancer Treatment (National Cancer Institute) Also in Spanish * Cervical Cancer Treatment by Stage (National Cancer ...
Even when abnormal cells are found, it may be difficult to give a definitive diagnosis of uterine sarcoma based directly on the ... Positive cervical or peritoneal cytology is uncommonly detected in association with uterine sarcomas. ... cytomorphologic characteristics of cervical or peritoneal smears. Howe … ... Uterine Neoplasms / chemistry * Uterine Neoplasms / diagnosis * Uterine Neoplasms / pathology* * Vaginal Smears Substances * ...
48 with cervical and vulvar condylomata, 14 with cervical intraepithelial neoplasia (CIN), 34 with chronic cervicitis and 24 ... with normal cervical epithelium were collected from different geographic regions with different cer … ... Biopsies from 318 cases with squamous cell carcinoma of the uterine cervix, ... Uterine Cervical Neoplasms / epidemiology * Uterine Cervical Neoplasms / genetics * Uterine Cervical Neoplasms / microbiology* ...
recurrent cervical cancer. *cervical squamous cell carcinoma. *Carcinoma, Squamous Cell. *Uterine Cervical Neoplasms ...
... uterine cervical neoplasm National Category Urology and Nephrology Identifiers. URN: urn:nbn:se:liu:diva-151632DOI: 10.1111/ ... The median number (range) of women with cervical cancer treated at each center annually was 32 (15-120). In 58% (11/19) of the ... Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countriesSurvey from the Surgical ... IntroductionWomen with cervical cancer in the Nordic countries are increasingly undergoing pretreatment imaging by ultrasound, ...
Keywords: Uterine Cervical Neoplasms, Neoplasms, Magnetic Resonance Imaging, Physical Examination Abstract View Paper Research/ ... uterine, and parametrium, cervical stroma invasion, mass size, pelvic and abductor lymph node metastasis were extracted from ... Eighty women with cervical cancer were evaluated and the mean age was 47.3 years. There was a statistically significant ... Cervical cancer is prevalent cancer among women that correct diagnosis has very important role in its treatment. ...
It is also overexpressed in uterine corpus endometrial and uterine carcinosarcomas. Another F-protein-protease is tryptase beta ... Its expression is also increased in a wide range of other malignant neoplasms. Factor X (F10) is frequently expressed in normal ... TMPRSS2 is overexpressed in cervical and endocervical squamous cell carcinomas, along with colon, prostate, and rectum ... It is also overexpressed in some cell lines originating from various malignant neoplasms. Thus, it is highly expressed in ...
Cancer of the uterine cervix is largely a preventable disease that is characterized by a long lead time. Precancerous lesions ... Sala E, Wakely S, Senior E, Lomas D. [MRI of malignant neoplasms of the uterine corpus and cervix.]. Radiologia. 2008 Nov-Dec. ... A small study found that whole-body diffusion-weighted imaging can distinguish normal uterine cervix from uterine cervical ... Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET. Mol Imaging Biol. 2009 Jul-Aug. 11(4):229-35. [ ...
... uterine cervical neoplasms; genital warts; cost-effectiveness; discount rate; hpv; quality-adjusted life year; cervical cancer ... vaccine prices and cervical cancer screening coverage.Vaccination of 12-year-old girls alongside current cervical cancer ... Estonia has high cervical cancer incidence and low screening coverage. We modelled the impact of population-based bivalent, ... Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage 2017. Võrno ...
Vaccination against Human Papilloma Virus (HPV) may help to reduce the incidence of cervical cancer. The aim of the study was ... Cervical cancer is the third most common cancer in women worldwide, with high incidence in lowest income countries. ... HPV is a requirement for developing cervical cancer and is found in 99.7% of cervical cancers diagnosed worldwide [4]. Two HPV ... of the high-grade cervical lesions that increase a womans risk for developing cervical cancer [5]. ...
Uterine Cervical Neoplasms 2 * Women's Health 2 * Lung 2 * Oncology Nursing 1 ... Genital Neoplasms, Female, Sexuality, Gynecology, General Surgery, Radiotherapy, Pathology, Ensayos Clínicos, Sicología, ...
Clinical value of the comprehensive treatment in intermediate and advanced cervical cancer with uterine arterial interventional ... Malignant neoplasm of the liver, not specified as primary or secondary. C78.7. Secondary malignant neoplasm of liver and ... Malignant neoplasm of colon. C47.0 - C47.9, C49.0 - C49.9. Malignant neoplasm of connective tissue and other soft tissue [ ... Malignant neoplasm of the liver and intrahepatic bile ducts. C47.0 - C47.9, C49.0 - C49.9. Malignant neoplasm of connective ...
Uterine Cervical Neoplasms. *Papanicolaou Test. *Oncology & Carcinogenesis. *Middle Aged. *Mass Screening. *Life Expectancy ... The absence of cervical screening in Vietnam and other developing countries is due in large part to the perceived expense of ... Suba, E. J., C. H. Nguyen, B. D. Nguyen, S. S. Raab, and S. S. Viet/American Cervical Cancer Prevention Project. "De novo ... BACKGROUND: Cervical carcinoma is the leading cause of cancer-related death among women in the developing world. ...
Key words: knowledge, risk factors, uterine cervical neoplasms, vaginal wet mount, womens health. ... What is cervical cancer?; 7) What are the causes of cervical cancer?; 8) How to prevent cervical cancer? ... OBJECTIVES: evaluating the level of information about the examination of uterine cervical cancer and its association with ... In a study in Pakistan25, 1.8% of the women did not know cervical cancer was a disease, and only 26% were aware of one or more ...
Uterine cancer is the only type of cancer not found on the List. Malignant neoplasms of the cervix uteri (invasive cervical ... If uterine cancer is added to the List in a final rule, the WTC Health Program can begin to certify cases of uterine cancer in ... The Administrator is proposing that all types of uterine cancer be added to the List, including malignant neoplasms of isthmus ... Addition of Uterine Cancer to the List of WTC-Related Health Conditions proposing the addition of uterine cancer to the List is ...
Cervical neoplasia in relation to socioeconomic and demographic factors - a nationwide cohort study (2002-2018). Jansåker, F., ...
Breast Neoplasms, Vaginal Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, 50234, 50233, Nevi and ... Neoplasms, Medical Oncology, Oncology Service, Hospital, Oncology Nursing, Radiotherapy, Antineoplastic Protocols, ... Antineoplastic Combined Chemotherapy Protocols, Precancerous Conditions, Genetics, Genes, Neoplasm, Neoplastic Stem Cells, ... Genes, Tumor Suppressor, Cancer Symptoms, Biomarkers, Pharmacological, General Surgery, Lung, Lung Neoplasms, Gynecology, ...
Uterine Cervical Neoplasms 21. Carcinoma of the vulva Publication: Houston : The Center, 1976 Subject(s): Vulvar Neoplasms 22. ... Uterine Neoplasms 34. DRS awards ceremony Publication: [Bethesda, Md. : National Institutes of Health, Medical Arts and ...
Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Mesothelioma, Malignant, ... Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Colorectal Neoplasms, Endometrial Neoplasms, ... Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms ...
Benign Neoplasms 2140.0 Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 ... Neoplasms Malignant Neoplasms 2100.0 Cancer, gastrointestinal tract Includes: Esophagus Stomach Small intestine Colon 2105.0 ... neoplasm of bone. In other words, change the 20 to V. NOTE: The use of prefixes facilitates the calculation of percent ... Cervical spine, neck Includes: Whiplash 5110.0 Back 5115.0 Knee 5120.0 Ankle 5125.0 Wrist 5130.0 Sprain or strain, other and ...
Benign Neoplasms 2140.0 Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 ... Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 Other benign neoplasms ... Neoplasms Malignant Neoplasms 2100.0 Cancer, gastrointestinal tract Includes: Esophagus Stomach Small intestine Colon 2105.0 ... Sprains and strains: 5105.0 Cervical spine, neck Includes: Whiplash 5110.0 Back 5115.0 Knee 5120.0 Ankle 5125.0 Wrist 5130.0 ...
Neoplasms, Hormone-Dependent 4 0 Psychiatric Status Rating Scales 4 0 Uterine Cervical Neoplasms 4 0 ...
Uterine Cervical Neoplasms. Uterine Neoplasms. Genital Neoplasms, Female. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. ... Uterine Cervical Diseases. Uterine Diseases. Genital Diseases, Female. Female Urogenital Diseases. Female Urogenital Diseases ... Cervical Cancer Biological: Pembrolizumab Drug: Paclitaxel Drug: Cisplatin Drug: Carboplatin Biological: Bevacizumab Drug: ... Has received prior systemic chemotherapy for treatment of cervical cancer.. *Has not recovered adequately from toxicity and/or ...
... malignant female breast neoplasm, female breast pain, positive cervical smear test, dysmenorrhea, endometrial disorder, ... uterine hemorrhage, vaginal hemorrhage, atrophic vaginitis, albuminuria, bladder discomfort, increased blood urea nitrogen, ... Neoplasms: basal cell carcinoma, squamous carcinoma. Nervous Disorders: carpal tunnel syndrome, coma, abnormal coordination, ... Urogenital Disorders: epididymitis, prostatic disorder, abnormal sexual function, amenorrhea, female breast neoplasm, ...
... malignant female breast neoplasm, female breast pain, positive cervical smear test, dysmenorrhea, endometrial disorder, ... uterine hemorrhage, vaginal hemorrhage, atrophic vaginitis, albuminuria, bladder discomfort, increased blood urea nitrogen, ... Neoplasms: basal cell carcinoma, squamous carcinoma Nervous Disorders: carpal tunnel syndrome, coma, abnormal coordination, ... Urogenital Disorders: epididymitis, prostatic disorder, abnormal sexual function, amenorrhea, female breast neoplasm, ...
CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm ... and uterine carcinosarcoma (Fig. 2). The results highlighted the important role of DLEU1 in carcinogenesis. ... Among the DElncRNAs, the expression of DLEU1 was upregulated in GBM and a number of other tumor types, including cervical ... uterine carcinosarcoma; num, number; T, tumour; N, normal. ... lymphoid neoplasm diffuse large B-cell lymphoma, brain lower ...
Results The mean EQ-5D-5L and EQ-VAS utility scores among patients of cervical cancer were 0.64 [95% CI=0.61-0.67] and 67.6 [95 ... Conclusion Cervical cancer significantly impacts the health-related quality of life of the patients in India. Clinical ... A total of 159 cervical cancer patients were interviewed. Mean EQ-5D-5L quality of life scores (utility scores) were calculated ... Introduction Estimation of health-related quality of life of cervical cancer patients in India is important in assessing the ...
Uterine Cervical Neoplasms 89% * Elderly 65% * Neoplastic Processes 25% * Papanicolaou Test 22% ... Clinical implications of screening for cervical cancer under Medicare: The natural history of cervical cancer in the elderly: ... Dive into the research topics of Clinical implications of screening for cervical cancer under Medicare: The natural history of ... cervical cancer in the elderly: What do we know? What do we need to know?. Together they form a unique fingerprint. ...
  • A research for the relationship between human papillomavirus and human uterine cervical carcinoma. (nih.gov)
  • Biopsies from 318 cases with squamous cell carcinoma of the uterine cervix, 48 with cervical and vulvar condylomata, 14 with cervical intraepithelial neoplasia (CIN), 34 with chronic cervicitis and 24 with normal cervical epithelium were collected from different geographic regions with different cervical cancer mortalities. (nih.gov)
  • The DNA.DNA dot-blot and Southern blot hybridization results show that there is a close relationship between HPV-16 and the uterine cervical squamous cell carcinoma in China. (nih.gov)
  • It is suggested that HPV-16 infection may be an etiological factor in the development of human cervical carcinoma. (nih.gov)
  • CT of clinical stage IIB cervical carcinoma. (medscape.com)
  • CT of a patient with stage IVB cervical carcinoma. (medscape.com)
  • BACKGROUND: Cervical carcinoma is the leading cause of cancer-related death among women in the developing world. (duke.edu)
  • Outcomes measured included life expectancy, cervical carcinoma incidence, cost per woman, and cost-effectiveness. (duke.edu)
  • Assuming 70% program participation, cervical carcinoma incidence will decrease from 26 in 100,000 to 14.8 in 100,000, and cost-effectiveness will be $725 per discounted life-year. (duke.edu)
  • Cytology-based screening methods for cervical adenocarcinoma (ADC) and to a lesser extent squamous-cell carcinoma (SCC) suffer from low sensitivity. (oncotarget.com)
  • Cancer of the uterine cervix (cervical cancer) is largely a preventable disease that is characterized by a long lead time. (medscape.com)
  • This image shows a hypoattenuating tumor occupying the entire cervix and extending to the outer posterior and right cervical margins. (medscape.com)
  • Cancer of the cervix is preventable through vaccination against human papillomavirus and by screening and treatment of cervical precancers. (stanford.edu)
  • Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms . (lookformedical.com)
  • Introduction: The screening program for cervical cancer in Sweden recommends the use of primary human papillomavirus (HPV) screening for women aged ≥30 to 65 years. (lu.se)
  • Current guidelines from the US Preventive Services Task Force and the American Cancer Society incorporate the use of cervical cytology and high-risk human papillomavirus tests performed every 3 to 5 years for screening in average-risk asymptomatic patients. (stanford.edu)
  • Background: The ability for women to self-collect human papillomavirus (HPV) samples can potentially reduce the risk of cervical cancer and increase screening coverage. (bvsalud.org)
  • To investigate the clinical role of nm23 expression in identifying both high‐risk human papillomavirus (HR‐HPV) and high‐grade cervical lesions or carcinomas [cervical intraepithelial neoplasia 2 + (CIN2 + )], and to compare it with p16 overexpression, as this latter biomarker has already been reported widely in HR‐HPV infected cervical lesions. (mcmaster.ca)
  • Chemoembolization (CE) for other indications including palliative treatment of liver metastases from other non-neuroendocrine primaries (e.g., breast cancer, cervical cancer, colon cancer, esophageal cancer, melanoma, rhabdomyosarcoma, or unknown primaries) and CE of the pancreas for pancreatic cancer. (aetna.com)
  • Cervical cancer is the second most frequent form of the disease among women, in Brazil, following non-melanoma skin cancer. (bvsalud.org)
  • Tumors usually extend one to eight segments in the cervical region. (magiran.com)
  • A white paper [PDF, 38 pages 2 MB] issued by the Program in September 2021 found that the available scientific evidence provided sufficient support to add uterine cancer to the List, but only for those Program members who already have certified WTC-related estrogen-secreting tumors. (cdc.gov)
  • This implies that E6 and E7 may be the oncogenic genes of HPV-16 and play an important role in the carcinogenesis of human cervical epithelial cells. (nih.gov)
  • The risk of cervical intra-epithelial neoplasia grade 2/3 (CIN2/3) in these women is low. (dundee.ac.uk)
  • Positive cervical or peritoneal cytology is uncommonly detected in association with uterine sarcomas. (nih.gov)
  • The absence of cervical screening in Vietnam and other developing countries is due in large part to the perceived expense of implementing Papanicolaou cytology screening services, although, to the authors' knowledge, the cost-effectiveness of establishing such services has never been studied in a developing country. (duke.edu)
  • OBJECTIVE: Worldwide, each year, large numbers of women are referred for colposcopy following low-grade abnormal cervical cytology. (dundee.ac.uk)
  • Outcomes included percentages reporting significant anxiety (HADS anxiety subscale score ≥11), significant depression (HADS depression subscale score ≥8) or worries about the result of the next cytology test, cervical cancer, having sex, future fertility and general health at each time point (point prevalence) and during follow-up (cumulative prevalence). (dundee.ac.uk)
  • To estimate the added cost of using cytology to identify each histologically confirmed cervical HSIL case among Aptima HPV-negative women, we used the current cost of €21.2 per cytology evaluation at our laboratory. (lu.se)
  • Adenocarcinoma cells were identified in both the cervical smear and peritoneal fluid of one patient with MMMT. (nih.gov)
  • Four patients, including one case of leiomyosarcoma (LMS), one high grade stromal sarcoma (HGSS) and two malignant mixed müllerian tumor (MMMT), had abnormal cervical and/or peritoneal cytologic findings. (nih.gov)
  • During fellowship she was trained in advanced colposcopy, high-resolution anoscopy (HRA) and treatment of cervical, vulvar, vaginal and anal disease. (stanford.edu)
  • [ 4 ] However, invasive cervical cancer remains a disease of significant morbidity, and it is a major cause of cancer deaths in women worldwide, although the incidence and mortality rates of invasive cervical cancer have declined substantially (particularly in countries that have well-developed screening programs). (medscape.com)
  • The purpose of this study is to evaluate the efficacy and safety of pembrolizumab plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer. (msdoncologyclinicaltrials.com)
  • We provided a comprehensive analysis of rate, pattern, and severity of early and late postoperative complications in a very large, single-institution series of locally advanced cervical cancer (LACC) patients administered CT/RT plus radical surgery (RS). (unicatt.it)
  • Cancers associés aux virus en Afrique. (who.int)
  • As many as 5% of cervical cancers may not be associated with HPV. (medscape.com)
  • Whereas the HPV-16 DNA sequence was only present as an episome in normal cervical epithelium and cervical benign lesions. (nih.gov)
  • Immunohistochemical evaluation of nm23 and p16 in 143 cervical biopsy specimens including negative, low‐ and high‐grade lesions and squamous carcinomas (SC). (mcmaster.ca)
  • The neoplasms may be histologically the same or different, and may be found in the same or different sites. (lookformedical.com)
  • The pathology records of 102 patients with uterine sarcoma were reviewed. (nih.gov)
  • Estonia has high cervical cancer incidence and low screening coverage. (fao.org)
  • Cervical cancer is the third most common cancer in women worldwide, with high incidence in lowest income countries. (biomedcentral.com)
  • Vaccination against Human Papilloma Virus (HPV) may help to reduce the incidence of cervical cancer. (biomedcentral.com)
  • Three abnormal cervical smears and two abnormal peritoneal fluids from these patients, including immunohistochemically stained sections of cell block, were reviewed. (nih.gov)
  • Even when abnormal cells are found, it may be difficult to give a definitive diagnosis of uterine sarcoma based directly on the cytomorphologic characteristics of cervical or peritoneal smears. (nih.gov)
  • Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. (lookformedical.com)
  • To study the cytologic features of uterine sarcoma. (nih.gov)
  • In addition, given the substantial morbidity and mortality associated with cervical cancer, effective strategies for its prevention and treatment are critical for improving women's health throughout the developing world [ 14 ]. (biomedcentral.com)
  • Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. (lookformedical.com)
  • [ 10 , 11 ] First intercourse at an early age, sexual promiscuity, high parity, race, and low socioeconomic status are thought to increase the risk for cervical cancer because these factors are linked to sexual behavior that increases the likelihood of exposure to HPV and/or because they are cofactors that modify the risk in women who are infected with HPV. (medscape.com)
  • The term "uterine cancer" in this proposal refers to all types of uterine cancer, including endometrial cancer. (cdc.gov)
  • Cervical cancer screening programmes : managerial guidelines. (who.int)
  • We modelled the impact of population-based bivalent, quadrivalent or nonavalent HPV vaccination alongside cervical cancer screening.A Markov cohort model of the natural history of HPV infection was used to assess the cost-effectiveness of vaccinating a cohort of 12-year-old girls with bivalent, quadrivalent or nonavalent vaccine in two doses in a national, school-based vaccination programme. (fao.org)
  • The results were most sensitive to changes in discount rate, vaccination regimen, vaccine prices and cervical cancer screening coverage.Vaccination of 12-year-old girls alongside current cervical cancer screening can be considered a cost-effective intervention in Estonia. (fao.org)
  • Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations. (stanford.edu)
  • Cervical cancer screening has evolved since the Pap smear was first discovered in the 1920s. (stanford.edu)
  • Objectives: To assess the willingness to HPV self-sampling for cervical cancer screening and its predictors among women attending outpatient clinics in Arusha region, northern Tanzania. (bvsalud.org)
  • Conclusion: The majority of women were willing to self-collect HPV samples for cervical cancer screening. (bvsalud.org)
  • The present survey reports the influence of pretreatment imaging findings on the recorded clinical International Federation of Gynecology and Obstetrics (FIGO) stage in Nordic countries and its impact on treatment planning and preferred surgical approach in cervical cancer. (diva-portal.org)
  • Neoplasms containing cyst-like formations or producing mucin or serum. (lookformedical.com)
  • This Clinical Policy Bulletin addresses treatment approaches for liver and other neoplasms. (aetna.com)
  • Percutaneous ethanol injection (PEI) for liver neoplasms when criteria above are not met. (aetna.com)